Sign in
Fas Inhibition With ONL1204 for the Treatment of Geographic Atrophy: First-Time Results From a Phase 1b Study
Durga Borkar, MD
Annual Meeting Talks
2024
Avacincaptad Pegol, A Novel C5 Inhibitor, Demonstrates Continued Reduction in Geographic Atrophy Growth: 18-Month Results From GATHER1 Clinical Trial
Jason Hsu, MD
2021
Complete and early vitrectomy with intravitreal moxifloxacin/dexamethasone for endophthalmitis
Raul Velez-Montoya, MD
On Demand Cases, Courses, and Papers
2019
Category: AMD-Neovascular